Exact Sciences Corp. Reports Board Changes and Compensation Updates

Ticker: EXAS · Form: 8-K · Filed: Apr 25, 2024 · CIK: 1124140

Exact Sciences CORP 8-K Filing Summary
FieldDetail
CompanyExact Sciences CORP (EXAS)
Form Type8-K
Filed DateApr 25, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, executive-compensation, board-of-directors

Related Tickers: EXAS

TL;DR

Exact Sciences filed an 8-K detailing board changes and executive comp updates.

AI Summary

Exact Sciences Corp. announced on April 25, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key personnel.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure regarding board and executive changes, not indicating immediate financial distress or significant operational shifts.

Key Players & Entities

FAQ

What specific items are covered in this 8-K filing?

This 8-K filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on April 25, 2024.

What is the company's principal executive office address?

The company's principal executive office is located at 5505 Endeavor Lane, Madison, WI 53719.

What is the company's IRS Employer Identification No.?

The company's IRS Employer Identification No. is 20-4782291.

What is the SEC file number for Exact Sciences Corp.?

The SEC file number for Exact Sciences Corp. is 001-35092.

Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-04-25 16:19:31

Key Financial Figures

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. Exhibits The exhibits required to be filed as a part of this Current Report on Form 8-K are listed below and incorporated herein by reference. Exhibit No. Exhibit Description 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EXACT SCIENCES CORPORATION Date: April 25, 2024 By: /s/ James Herriott James Herriott Senior Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing